All tumors underwent routine IHC to confirm the LMS diagnosis utilizing smooth muscle markers (SMA, desmin, or H‐caldesmon) and melanoma markers (HMB45, Melan A) to exclude PEComa. Here, PMEL is linked to neoplasm with perivascular epithelioid cell differentiation.